Peter Godolphin wins Prostate Cancer Foundation Young Investigator Award

25 Oct 2023

Peter Godolphin, Senior Research Fellow at the MRC Clinical Trials Unit at UCL, has been named as one of 28 Prostate Cancer Foundation (PCF) Class of 2023 Young Investigators. The fellowships are awarded to future leaders in the field of prostate cancer, who will receive career and project support as well as funding for their research.

Peter was awarded the 2023 John Black Charitable Foundation – PCF Young Investigator Award to investigate methods of determining which treatments work best for which people with metastatic, hormone-sensitive prostate cancer, and the best ways to communicate information on treatment selections.

Recently, scientists have developed several new life-prolonging treatments for people with hormone-sensitive prostate cancer, including docetaxel, abiraterone and enzalutamide. But it is uncertain which patients will benefit most from which treatment.

Peter and his team will analyse clinical trial data and perform simulation studies to identify the best patient-level, clinical, imaging and/or molecular biomarkers to predict how patients will respond to different treatments. This will inform recommendations on which methods to use for selecting treatments in practice, as well as in trials and meta-analyses.

The team will also hold workshops with patients, clinicians, statisticians and trialists to understand current challenges for communicating results of these studies and develop tools for improving communication.

This work will help ensure that treatments are targeted at the appropriate patients and de-escalated when they are not required, ultimately improving outcomes for people with prostate cancer.

Further information: